Granules India Limited
BNP Paribas bought 13,18,051 shares of Granules India Limited for ₹115.00 Cr at ₹872.50 apiece in a block deal.
A pharmaceutical manufacturer engaged in producing Active Pharma Ingredients, Pharmaceutical Formulation Intermediates, and finished dosages for global markets. Granules India operates integrated manufacturing facilities across multiple locations in India, serving domestic and international customers in the pharmaceutical sector. The company specializes in complex chemical synthesis and formulation development for various therapeutic categories, including antibiotics, cardiovascular, and gastroenterology segments.
French global bank with around EUR 2.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.